Daryl Griffin

5PUBLICATIONS
47CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 26, 2025
Drug-tolerant persisters and immunotherapy persister cells exhibit cross-resistance and share common survival mechanisms.

Maria Davern, Cole J Turner, Daryl Griffin

|Oct 07, 2025
BET Bromodomain Inhibition Reverses CDK4/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer via Induction of miR-34a-5p.

Renyan Liu, Xin Wang, Timothy B Branigan

|Jul 31, 2024
Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.

Daryl Griffin, Robbie Carson, Debbie Moss

|Oct 24, 2022
Bcl-xL Is a Key Mediator of Apoptosis Following KRASG12C Inhibition in KRASG12C-mutant Colorectal Cancer.

Hajrah Khawaja, Rebecca Briggs, Cheryl H Latimer

|Jun 26, 2021
The clinical and molecular significance associated with STING signaling in breast cancer.

Eileen E Parkes, Matthew P Humphries, Elaine Gilmore

Pageof 1